Dedicated to Pharmaceutical Innovation

Impax Laboratories is a technology-based specialty pharmaceutical company utilizing our controlled-release and other in-house development and formulation expertise. We have a balanced business model that consists of a successful generic business targeting high-value Abbreviated New Drug Applications (ANDA) and a brand strategy with the potential to drive higher long-term growth.

Corporate Headquarters

Mailing address:
30831 Huntwood Ave.
Hayward, CA 94544
(510) 240-6000

Visitors:
31047 Genstar Rd.
Hayward, CA 94544
(510) 240-6000

Research Areas

We have a dual strategic focus that stretches across our generic division, Global Pharmaceuticals, and our branded division, Impax Pharmaceuticals.

Our generic business strategy is focused on targeting high-margin, first-to-file or first-to-market product opportunities. We explore a broad range of therapeutic areas that have technically challenging drug delivery mechanisms or other niches which may result in lessened competition. We are also developing specialty generic products we believe present one or more competitive barriers to entry.

Our brand business strategy is focused on central nervous system, or CNS disorders. We are applying our formulation expertise and clinical development experience to develop differentiated, modified or controlled-release versions of currently marketed drug products.

Growth Strategy

We are focused on adding to the growth our own innovations will bring with acquisitions of external growth opportunities. Our business development activities are focusing on technologies in new dosage forms, or products or companies where our core competency in creative technologies and methods can result in synergies from further technical innovation. These could be in either generic or proprietary opportunities complementary to our own creative efforts.